NOS3 and chronic kidney disease: Studies have also shown CLT to increase the levels of nitric oxide (NO) by increasing endothelial nitric oxide synthase (eNOS) whilst inhibiting VCAM-1, thus decreasing inflammation in a murine model of CKD [138].